Srx inhibitor induces the accumulation of sulfinic peroxiredoxins and ROS.
Srx inhibitor causes the death of cancer cells by oxidative mitochondrial damage.
Srx inhibitor leads to preferential death of cancer cells over normal cells.
Srx inhibitor suppresses the growth of xenograft tumors without acute toxicity.
Targeting Srx might be a novel therapeutic strategy for cancer treatment.